Jump Financial, LLC Amneal Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$5.24 - $6.34 $183,950 - $222,565	-35,105 Reduced 53.11%	30,995 $187,000
Q4 2023 Oct 21, 2024	SELL	$3.36 - $6.21 $29,232 - $54,027	-8,700 Reduced 11.63%	66,100 $401,000
Q4 2023 Feb 07, 2024	SELL	$3.36 - $6.21 $29,232 - $54,027	-8,700 Reduced 11.63%	66,100 $401,000
Q3 2023 Oct 21, 2024	BUY	$2.76 - $4.59 $206,447 - $343,332	74,800 New	74,800 $315,000
Q3 2023 Nov 07, 2023	BUY	$2.76 - $4.59 $206,447 - $343,332	74,800 New	74,800 $315,000
Q3 2022 Nov 07, 2022	BUY	$2.02 - $3.62 $105,646 - $189,326	52,300 New	52,300 $105,000
Q2 2022 Aug 09, 2022	SELL	$3.01 - $4.46 $54,781 - $81,172	-18,200 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$3.9 - $4.89 $33,540 - $42,054	-8,600 Reduced 32.09%	18,200 $76,000
Q4 2021 Feb 10, 2022	BUY	$3.95 - $5.85 $39,105 - $57,915	9,900 Added 58.58%	26,800 $129,000
Q3 2021 Nov 12, 2021	BUY	$4.31 - $5.64 $72,839 - $95,316	16,900 New	16,900 $90,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.26B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.